Clarus Therapeutics Holdings, Inc. (CRXTQ)

USD 0.0

(0.0%)

Operating Expenses Summary of Clarus Therapeutics Holdings, Inc.

  • Clarus Therapeutics Holdings, Inc.'s latest annual operating expenses in 2021 was 50.96 Million USD , up 13.62% from previous year.
  • Clarus Therapeutics Holdings, Inc.'s latest quarterly operating expenses in 2022 Q2 was 13.54 Million USD , down -19.85% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a annual operating expenses of 44.85 Million USD in annual operating expenses 2020, down 0.0% from previous year.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly operating expenses of 16.89 Million USD for 2022 Q1, down 0.0% from previous quarter.
  • Clarus Therapeutics Holdings, Inc. reported a quarterly operating expenses of 50.96 Million USD for 2021 FY, up 13.62% from previous quarter.

Annual Operating Expenses Chart of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Historical Annual Operating Expenses of Clarus Therapeutics Holdings, Inc. (2021 - 2020)

Year Operating Expenses Operating Expenses Growth
2021 50.96 Million USD 13.62%
2020 44.85 Million USD 0.0%

Peer Operating Expenses Comparison of Clarus Therapeutics Holdings, Inc.

Name Operating Expenses Operating Expenses Difference
AstraZeneca PLC 29.57 Billion USD 99.828%
Bristol-Myers Squibb Company PFD CONV 2 17.07 Billion USD 99.701%
CSPC Pharmaceutical Group Limited 2.14 Billion USD 97.626%
Novartis AG 24.87 Billion USD 99.795%
PT Kalbe Farma Tbk. 11823.24 Billion USD 100.0%